FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to (S)-α-phenyl-2-pyridine ethaneamine of the formula (I) and its salts with inorganic acids showing anticonvulsant activity (value α = 3.7 mg/kg). Invention relates to also a drug showing anticonvulsant effect and containing a substance of the formula (I) taken at effective amount and pharmaceutically acceptable additions. Invention relates to also a method of treatment of patients with convulsions by administration of therapeutically effective dose of compound (I). Invention relates to also a method of synthesis of compound (I) that involves treatment of racemic ED50-phenyl-2-pyridine ethaneamine with chiral acid followed by selective precipitation of diastereomeric salt. EFFECT: improved method of synthesis, enhanced effectiveness of compound. 8 cl, 1 dwg, 2 ex
| Title |
Year |
Author |
Number |
| BICYCLIC DERIVATIVES OF AMIDINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF NITROGEN OXIDE SYNTHETASE ACTIVITY |
1995 |
- Dzhejms Ehdvin Makdonald
- Vill'Jam Kelvin Shekspir
- Robert Dzhon Mjurrej
- Dzhejms Rassell Mehts
|
RU2155761C2 |
| BICYCLIC DERIVATIVES OF ISOTHIOUREA, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1996 |
|
RU2157802C2 |
| CARBAMIC ACID AZABICYCLIC ESTERS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS |
1997 |
|
RU2172739C2 |
| DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 |
2002 |
- Al'Stermark Lindstedt Ehva-Lotte
- Ol'Sson Anna Kristina
- Li Lanna
|
RU2303031C2 |
| SPIRO-AZABICYCLIC COMPOUNDS, METHODS OF THEIR SYNTHESIS AND INTERMEDIATE COMPOUNDS |
1995 |
- Majkl Balestra
- Dzhon Charlz Gordon
- Ronald Konrad Griffit
- Robert Dzhon Mjurrej
|
RU2148058C1 |
| 7-CHLORO-4-HYDROXY-2-(2-CHLORO-4-METHYLPHENYL)-1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-B]QUINOLINE-1,10-DIONE, METHOD FOR PAIN TREATMENT, PHARMACEUTICAL COMPOSITIONS |
2000 |
- Behr Tomas Majkl
- Braun Din Gordon
- Merfi Mehgan
- Urbanek Rebekka Ehnn
- Ksjao Uehnkhuehj
|
RU2234507C2 |
| MODULATOR OF NMDA-RECEPTOR WITH STABILISED SECONDARY STRUCTURE AND ITS USAGE |
2011 |
|
RU2566821C2 |
| REFLUX INHIBITORS |
1997 |
- Ehndrjus Pol L.R.
- Lekhmann Anders
|
RU2199316C2 |
| USE OF 5-(2-CHLORO-1-HYDROXYETHYL)-4-METHYLTHIAZOLE FOR DECREASE OF NEURON DAMAGE, SUPPRESSION OF CONVULSE AND MOTOR ACTIVITY DECREASE |
1991 |
- Bernard Robin Bor[Gb]
- Alan Dzhon Kross[Gb]
- Al'Fred Richard Grin[Gb]
- Kurt-Ehrik Khagberg[Se]
|
RU2093155C1 |
| 3,5-DISUBSTITUTED PHENYL-PYPERIDINES AS DOPAMINE NEUROTRANSMISSION MODULATORS |
2006 |
|
RU2418787C2 |
